Repurposed drugs may have a speedier path to clinical use because they have already been shown to be safe in people. A study publishing May 19 in the open access journal PLOS Pathogens by Sandrine Belouzard and Jean Dubuisson at Pasteur Institute, Lille, France, and colleagues suggests clofoctol may be an effective treatment for SARS-CoV-2 infections in mice.
Repurposed antibiotic may be an effective therapeutic in COVID-19–infected mice
Repurposed drugs may have a speedier path to clinical use because they have already been shown to be safe in people. A study publishing May 19 in the open access journal PLOS Pathogens by Sandrine Belouzard and Jean Dubuisson at Pasteur Institute, Lille, France, and colleagues suggests clofoctol may be an effective treatment for SARS-CoV-2 infections in mice.